Zum Hauptinhalt springen

Hyperhidrose

Zuletzt bearbeitet: Zuletzt revidiert:
Zuletzt revidiert von:
  • Deutsche Dermatologische Gesellschaft. Definition und Therapie der primären Hyperhidrose. AWMF-Leitlinie Nr. 013-059. S1, Stand 2017. www.awmf.org 
  1. Deutsche Dermatologische Gesellschaft. Definition und Therapie der primären Hyperhidrose. AWMF-Leitlinie Nr. 013-059. S1, Stand 2017. register.awmf.org  
  2. Strutton DR, et al. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey. Journal of the American Academy of Dermatology. Vol. 51, Issue 2, P241-248, August 01, 2004. www.jaad.org  
  3. Doolittle J, et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016 Dec;308(10):743-49. link.springer.com  
  4. Schlereth T. Hyperhidrose – Ursachen und Therapie von übermäßigem Schwitzen. Dtsch Arztebl Int 2009; 106(3): 32-7. www.aerzteblatt.de  
  5. Kyung M Ro, et al. Palmar hyperhidrosis: Evidence of genetic transmission. Journal Of Vascula Surgery. Volume 35, Issue 2, P382-386, February 01, 2002. www.jvascsurg.org  
  6. Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ 2005; 172: 69–75. www.ncbi.nlm.nih.gov  
  7. Smetana GW, et al. Evaluation of the patient with night sweats or generalized hyperhidrosis, Zugriff 15.01.2023. www.uptodate.com  
  8. Korpelainen JT. Asymmetric sweating in stroke: a prospective quantitative study of patients with hemispheral brain infarction. Neurology . 1993 Jun;43(6):1211-4. pubmed.ncbi.nlm.nih.gov  
  9. Hornberger J, Grimes K, Naumann M, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004; 51:274. pubmed.ncbi.nlm.nih.gov  
  10. Kowalski JW, et al. Validity and reliability of the hyperhidrosis disease severity scale (HDSS). Journal Of The American Acadamy of Dermatology. Volume 50, Issue3, Supplement, P51, March 01, 2004. www.jaad.org  
  11. Baumgartner FJ, et al. Hyperhydrosis, bestpractice.bmj.com, Zugriff 15.01.2023. bestpractice.bmj.com  
  12. Hund M, et al. Randomisierte, plazebokontrollierte klinische Doppelblindstudie zur Wirksamkeit und Verträglichkeit der oralen Therapie mit Methantheliniumbromid (Vagantin®) bei fokaler Hyperhidrose. Journal Of The German Society of Dermatology, J Dtsch Dermatol Ges . 2004 May;2(5):343-9. onlinelibrary.wiley.com  
  13. Muller C, et al. Efficacy and safety of methantheline bromide (Vagantin((R)) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. Joural Of The European Acadeny Of Dermatology And Venereology. 2013; 27: 1278-84. onlinelibrary.wiley.com  
  14. Altmeyers Enzyklopädie. Zugriff 15.01.2023 www.altmeyers.org  
  15. McConaghy JR, et al. Hyperhidrosis: Management Options. Am Fam Physician. 2018 Jun 1;97(11):729-734. pubmed.ncbi.nlm.nih.gov  
  16. Fan YM, Wu ZH, Li SF, et al. Axillary osmidrosis treated by partial removal of the skin and subcutaneous tissue en bloc and apocrine gland subcision. Int J Dermatol 2001; 40: 714-6. pubmed.ncbi.nlm.nih.gov  
  17. Park YJ, Shin MS. What is the best method for treating osmidrosis? Ann Plast Surg 2001; 47: 303-9. pubmed.ncbi.nlm.nih.gov  
  18. Scholes KT, et al. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J. 1978 Jul 8;2(6130):84-5. www.ncbi.nlm.nih.gov  
  19. Neue Studien zu aluminiumhaltigen Antitranspirantien: Gesundheitliche Beeinträchtigungen durch Aluminium-Aufnahme über die Haut sind unwahrscheinlich Stellungnahme 030/2020 des BfR vom 20. Juli 2020. Zugriff 17.01.2023. www.bfr.bund.de  
  20. Bundesinstitut für Risikobewertung. Aluminiumhaltige Antitranspirantien tragen zur Aufnahme von Aluminium bei. Stellungnahme Nr. 007/2014, 2014. Zugriff 17.01.2023. mobil.bfr.bund.de  
  21. Arnold MJ, et al. Glycopyrronium (Qbrexza) Topical Wipes for Hyperhidrosis. Am Fam Physician. 2019 Sep 15;100(6):372-373. www.aafp.org  
  22. Glaser DA, et al. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials. J Am Acad Dermatol. 2019;80(1):128. Epub 2018 Jul 10. www.jaad.org  
  23. Nwannunu CE, et al. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis. Skin Therapy Lett. 2019 Mar;24(2):1-3. www.skintherapyletter.com  
  24. Abels C, et al. A 1% glycopyrronium bromide cream for the topical treatment of primary axillary hyperhidrosis: Efficacy and Safety Results from a Phase 3a Randomised Controlled Study. Br J Dermatol. 2021 Jan 14. www.ncbi.nlm.nih.gov  
  25. Gee S, Yamauchi PS. Nonsurgical management of hyperhidrosis. Thorac Surg Clin. 2008;18:141-155. PubMed  
  26. Dolianitis C, Scarff CE, Kelly J, et al. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Australas J Dermatol. 2004;45:208-212. PubMed  
  27. Karakoc Y, Aydemir EH, Kalkan MT, Unal G. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int J Dermatol 2002;41:602-5. PubMed  
  28. Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg 2002;28:495-9. PubMed  
  29. Blaheta HJ, Vollert B, Zuder D, Rassner G. Intravenous regional anesthesia (Bier's block) for botulinum toxin therapy of palmar hyperhidrosis is safe and effective. Dermatol Surg 2002;28:666-71. PubMed  
  30. Lowe NJ, Glaser DA, Eadie N, et al, for the North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 2007; 56: 604-11. pubmed.ncbi.nlm.nih.gov  
  31. Naumann M, et al. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323(7313):596. www.bmj.com  
  32. Heckmann M, et al. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344(7):488. www.nejm.org  
  33. Abtahi-Naeini B, et al. Quality of life in patients with primary axillary hyperhidrosis before and after treatment with fractionated microneedle radiofrequency. J Res Med Sci. 2015; 20: 631-5. www.ncbi.nlm.nih.gov  
  34. Abtahi-Naeini B, et al. Treatment of Primary Axillary Hyperhidrosis by Fractional Microneedle Radiofrequency: Is it Still Effective after Long-term Follow-up? Indian J Dermatol. 2016; 61: 234. www.ncbi.nlm.nih.gov  
  35. Glaser DA, et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study. Dermatol Surg. 2012 Feb;38(2):185-91. Epub 2012 Jan 30. pubmed.ncbi.nlm.nih.gov  
  36. Nestor MS, Park H. Safety and Efficacy of Micro-focused Ultrasound Plus Visualization for the Treatment of Axillary Hyperhidrosis. J Clin Aesthet Dermatol. 2014; 7:14-21. www.ncbi.nlm.nih.gov  
  37. Bechara FG, Sand M, Tomi NS, et al. Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective. Br J Dermatol. 2007;157:739-743. PubMed  
  38. Bechara FG, Altmeyer P, Sand M, et al. Surgical treatment of axillary hyperhidrosis. Br J Dermatol. 2007;156:398-399. PubMed  
  39. Cerfolio RJ, De Campos JR, Bryant AS, et al. The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642-1648. pubmed.ncbi.nlm.nih.gov  
  40. Moraites E, Vaughn OA, Hill S. Endoscopic thoracic sympathectomy. Dermatol Clin 2014 Oct; 32(4): 541-8. pmid:25152348 www.ncbi.nlm.nih.gov  
  41. Brackenrich J, et al. Hyperhidrosis, In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. 2022 Oct 3. www.ncbi.nlm.nih.gov  
  42. Neumayer C, Panhofer P, Zacherl J, Bischof G. Effect of endoscopic thoracic sympathetic block on plantar hyperhidrosis. Arch Surg. 2005; 140: 676-80. pubmed.ncbi.nlm.nih.gov  
  43. Sergi R, et al. Hyperhidrosis treatment with bornaprine in the acute phase of spinal cord-injured patients. Spinal Cord, 2008 Aug;46(8):571-3 www.nature.com  
  • Christina Weingartner, Dr. med., Ärztin in Weiterbildung Allgemeinmedizin, München